Martin Sundqvist
Overview
Explore the profile of Martin Sundqvist including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
71
Citations
579
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bjornberg A, Nestor D, Peker N, Sinha B, Couto N, Rossen J, et al.
APMIS
. 2025 Jan;
133(1):e13511.
PMID: 39807079
Shotgun metagenomics offers a broad detection of pathogens for rapid blood stream infection of pathogens but struggles with often low numbers of pathogens combined with high levels of human background...
2.
Kornfalt Isberg H, Sundqvist M, Melander E, Beckman A, Hedin K
JAC Antimicrob Resist
. 2024 Dec;
7(1):dlae214.
PMID: 39734489
Background: , the most common bacterium causing urinary tract infections (UTIs), is increasingly reported as resistant to multiple antibiotics. Swedish surveillance data from hospital and primary health care (PHC) report...
3.
Montgomery S, Vingeliene S, Li H, Backman H, Udumyan R, Jendeberg J, et al.
Brain Commun
. 2024 Dec;
6(6):fcae406.
PMID: 39659973
Demyelinating diseases including multiple sclerosis are associated with prior infectious exposures, so we assessed whether SARS-CoV-2 infection is associated with subsequent diagnoses of non-multiple sclerosis demyelinating diseases and multiple sclerosis....
4.
Dyrdak R, Hodcroft E, Broddesson S, Grabbe M, Franklin H, Gisslen M, et al.
Euro Surveill
. 2024 Oct;
29(41).
PMID: 39392000
BackgroundDespite the unprecedented measures implemented globally in early 2020 to prevent the spread of SARS-CoV-2, Sweden, as many other countries, experienced a severe first wave during the COVID-19 pandemic.AimWe investigated...
5.
Berinson B, Davies E, Torpner J, Flinkfeldt L, Fernberg J, Aman A, et al.
J Clin Microbiol
. 2024 Sep;
62(10):e0045824.
PMID: 39324811
Importance: Increasing antimicrobial resistance underscores the need for new diagnostic solutions to guide therapy, but traditional antimicrobial susceptibility testing (AST) is often inadequate in time-critical diseases such as sepsis. This...
6.
Germuskova Z, Sosa E, Campillay Lagos A, Aamot H, Beale M, Bertelli C, et al.
Microbes Infect
. 2024 Sep;
26(8):105410.
PMID: 39218348
No abstract available.
7.
Sall O, Eriksson L, Berhane I, Persson A, Magnuson A, Thulin Hedberg S, et al.
Epidemiol Infect
. 2024 Aug;
152():e99.
PMID: 39168652
No abstract available.
8.
Widen J, Moren J, Molling P, Fagerstrom A, Enblad P, Eriksson B, et al.
Infect Dis (Lond)
. 2024 Mar;
56(7):521-530.
PMID: 38530119
Objective: Investigate the performance of real-time 16S PCR and third-generation 16S sequencing in the diagnosis of external ventricular drain related infections (EVDRI). Methods: Subjects with suspected EVDRI were prospectively included...
9.
Pallon J, Sundqvist M, Hedin K
BMC Prim Care
. 2024 Jan;
25(1):15.
PMID: 38184547
Background: Rapid antigen detection tests (RADT) for Group A streptococci (GAS) and point-of-care tests for C-reactive protein (CRP) are commonly used in patients with pharyngotonsillitis in Sweden and Denmark although...
10.
Haars J, Palanisamy N, Wallin F, Molling P, Lindh J, Sundqvist M, et al.
Microorganisms
. 2023 Oct;
11(10).
PMID: 37894075
Monoclonal antibodies (mAbs) are an important treatment option for COVID-19 caused by SARS-CoV-2, especially in immunosuppressed patients. However, this treatment option can become ineffective due to mutations in the SARS-CoV-2...